Clinical Nutrition Market to grow at 7% CAGR from 2017 to 2024

1
Global Clinical Nutrition Market to surpass 80
billion by 2024 Fractovia.org
Fuel Cell Market size worth 25.5bn by 2024
2
Key Insights of Clinical Nutrition Market

• The growing geriatric population, rise in the
  number of metabolic disorders, and an increase in
  the number of premature births are key factors
  that will propel clinical nutrition market, which
  was worth USD 40 billion in 2015, and will grow
  at a CAGR of 7 over 2017-2024.
• The world is witnessing a rise in the number of
  disorders subject to the lack of proper
  nutrition, as per scientists.
• Clinical nutrition market is controlled by a
  specific number of leading players accounting for
  a major share.
• Pertaining to the growth of clinical nutritional
  market in India and China, APAC is likely to
  experience a massive growth over the years ahead.
  
• Infant products accounted for more than 55 of
  clinical nutrition market in 2015, and is likely
  to grow at a CAGR of 9 over 2017-2024.
• Milk based infant products contributed to more
  than 70 of infant clinical nutrition industy
  share in 2015, and will cross a revenue of more
  than USD 35 billion by 2024, subject to the
  rising inclination toward tasty, tolerant,
  healthy milk-based nutritional products for
  toddlers.

3
Continued

• Parenteral nutritional products are fairly
  prominent in the product landscape of clinical
  nutrition market, having held a valuation of more
  than USD 4.2 billion in 2015.
• Amino acids accounted for more than 40 of
  parenteral clinical nutrition market share in
  2015 and will grow substantially over 2017-2024,
  subject to the fact that they effectively help
  address the body metabolism issues.
• In 2015, U.S. clinical nutrition market size was
  worth more than USD 8 billion, and will grow at a
  rate of 6 over 2017-2024.
• In 2015, UK accounted for more than 17 of Europe
  clinical nutrition market share, subject to the
  increasing disposable incomes of patients and the
  rising expenditure on healthcare.
• Companies such as Hospira, Baxter International,
  Danone, B Braun Melsungen, Nestle, Mead Johnson,
  Perrigo, Fresenius Kabi, Abbott Laboratories, and
  H. J. Heinz mainly operate in this industry, and
  are engaged in tried-and-tested as well as
  innovative growth strategies to expand their
  business and provide a competitive edge to their
  rivals.

4
Europe Clinical Nutrition Market, By Product,
2012 - 2024 (USD Million)

5

Browse Full Market Research Report of Clinical
Nutrition Market _at_ http//bit.ly/2q1grC7
Request for a Sample of this Research
report _at_ https//www.fractovia.org/request-sample
/469
6
Table of Contents
Chapter 1. Methodology Scope 1.1  Research
Methodology                    1.1.1 Initial
data exploration       1.1.2 Statistical model
and forecast        1.1.3 Industry insights and
validation      1.1.4 Market definition and
forecast parameters 1.2 Data Sources              
        1.2.1 Primary     1.2.2
Secondary             Chapter 2. Executive
Summary 2.1  Clinical Nutrition industry 3600
synopsis, 2012 - 2024             2.1.1 Business
trends    2.1.2 Product trends      2.1.3
Regional trends    Chapter 3. Clinical Nutrition
Industry Insights 3.1 Industry segmentation       
               3.2 Industry size forecast, 2012
- 2024 3.3 Industry ecosystem analysis 3.3.1
Distribution channel analysis          3.4
Industry impact forces                     
7
Continued
3.4.1 Growth Drivers      3.4.1.1 Increasing
metabolic disorders and other chronic
diseases 3.4.1.2 Junk food habits leading to
malnourishment in U.S. Europe 3.4.1.3
Increasing geriatric population 3.4.1.4
Increasing rate of pre-mature birth birth rate
in APAC 3.4.1.5 Increasing adoption of home
healthcare in North America and Europe 3.4.2
Industry pitfalls Challenges         3.4.2.1
Stringent government regulations in U.S., Europe,
and APAC 3.4.2.2 Lack of awareness regarding
nutrition in developing countries 3.5 Growth
potential analysis                 3.6 Regulatory
landscape                      3.6.1
U.S.         3.6.2 Europe     3.6.3
China        3.7 Reimbursement scenario 3.7.1
U.S. 3.7.2 Europe 3.8 Pipeline analysis
8
Continued
3.9 Pricing analysis 3.9.1 North America 3.9.2
Europe 3.9.3 Asia Pacific 3.9.4 Latin
America 3.9.5 MEA 3.10 Volume analysis 3.10.1
North America 3.10.2 Europe 3.10.3
Asia-Pacific 3.10.4 Latin-America 3.10.5 Middle
East Africa 3.11 Patent Landscape 3.11.1
Infant nutrition 3.11.2 Enteral
Nutrition 3.11.3 Parenteral nutrition 3.12
Porter's Analysis                3.13 PESTEL
Analysis   3.14 Company market share analysis,
2016 3.14.1. Revenue 3.14.2. Product
landscape 3.14.2. Strategic landscape
9
Stay In Touch Website https//www.fractovia.org
Social Media